feed,title,long_url,short_url
Benzinga,AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease,https://benzinga.com/general/biotech/23/06/33001450/astrazeneca-seeks-expanded-use-for-soliris-as-first-targeted-therapy-for-pediatric-patients-with-,https://da.gd/xOvU
